Italian glass manufacturer Bormioli Pharma has completed the acquisition of GCL Pharma.
GCL Pharma is an Italian company that specialises in pharma closures.
Bormioli Pharma said: “It’s a new and relevant step in the right direction along our growth path, allowing us to serve the global pharma industry with more energy and renewed resources.”
The pharmaceutical glassmaker issued a binding offer of €8.9 million last month for GCL, which is a subsidiary of the Guala Closures Group.
GCL specialises in the production of plastic, rubber and aluminium closures for pharmaceutical applications.
In 2019 GCL Pharma recorded a turnover of approximately €8 million. The company’s main premises and production plant are located in Vasto, Chieti, Italy.
07.05.2020, Bormioli Pharma
此网站新闻材料的版权属于公司或第三方的新闻提供者，其所有权利保留。所有新闻材料对其访问者只能限于其本人使用，并且使用此材料的风险由其使用者独自自行承担。严禁对新闻材料进行再次发布和其它商业利用. 作为商业贸易的用途。如果新闻材料由第三方提供，当应用此新闻材料时，每个使用者都同意遵守，并且受此特定的项目的约束。Glass Global并不代表及认可新闻材料中所包含的内容及新闻中的外部网站的内容的准确性及可靠性。
Should the content or the design of these sites violate third parties rights or legal prescriptions, we kindly ask you to send us a respective message without invoice or cost. We guarantee that passages where the claim is considered as justified will be removed immediately, without any necessity to involve any lawyer into this issue. We will reject any claim caused by submission of a honorary note in this regard without any prior contact and confirmation of the issueby us and we reserve the right ssue counter claim ourselves because of violation of aforesaid conditions.